3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
4
Triple Negative Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Cancer Patients
1
Pancreatic Neoplasms
1
Locally Advanced Rectal Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Cisplatin
7
Radiotherapy, Intensity-Modulated
6
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
pembrolizumab
5
Cetuximab
5
(225)Ac-DOTA-c(RGDyK)
4
Carboplatin
3
Biopsy
3
ipatasertib
2
X-Rays
2
Taxes
2
Radiotherapy
2
Radiation
2
Paclitaxel
2
Interviews as Topic
2
Immunoglobulin G
2
Disulfides
2
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
camrelizumab
×
90 days
×
Clear all
No trials found.